Goniophotography and EyeCam imaging both highly sensitive

Article

Goniophotography and EyeCam imaging are both highly sensitive for detecting gonioscopic angle closure.

Goniophotography and EyeCam imaging are both highly sensitive for detecting gonioscopic angle closure.

A prospective, hospital-based, cross-sectional investigation, completed by Dr Mani Baskaran et al., Singapore Eye Research Institute and Singapore National Eye Centre, Singapore, included 85 eyes of 85 patients. Each participant underwent gonioscopy by a single observer and EyeCam imaging and goniophotography by various operators.

Angle closure was present in 38 eyes with gonioscopy, 40 eyes with the EyeCam and 40 eyes with goniophotography. There was high agreement between angle closure diagnosis and the two imaging modalities.

However, the agreement between the EyeCam and goniophotography was not as significant, due to lack of agreement in the nasal and temporal quadrants. Both EyeCam and goniophotography have similarly high sensitivity and specificity when detecting gonioscopic angle closure.

The abstract was published online in the Journal of Glaucoma.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.